source
- This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and moreWelcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This wee…raps · 14d ago↗ source
- STAT+: Fresh turmoil roils American Diabetes Association following controversy at conferenceTurmoil at the ADA has taken a fresh turn, with leaders blocking editors at its flagship journal from publishing pieces detailing a controversy at the group’s annual meeting.STAT · 14d ago↗ source
- Predicting biotech clinical trials and a new Alzheimer’s drug controversyThis week on "The Readout LOUD" podcast: a new Alzheimer's drug controversy and prediction markets for clinical trials and FDA drug reviews. Listen now.